{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T03:38:54Z","timestamp":1771299534032,"version":"3.50.1"},"reference-count":134,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ejmech.2021.113753","type":"journal-article","created":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T04:42:45Z","timestamp":1628397765000},"page":"113753","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Strategies in the design and development of (TAR) DNA-binding protein 43 (TDP-43) binding ligands"],"prefix":"10.1016","volume":"225","author":[{"given":"Praveen P.N.","family":"Rao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arash","family":"Shakeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6261-6351","authenticated-orcid":false,"given":"Yusheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4203-0887","authenticated-orcid":false,"given":"Frederic","family":"Calon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113753_bib1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0888-7543(03)00214-3","article-title":"Structural diversity and functional implications of the eukaryotic TDP gene family","volume":"83","author":"Wang","year":"2004","journal-title":"Genomics"},{"key":"10.1016\/j.ejmech.2021.113753_bib2","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.mcn.2007.03.007","article-title":"TDP-43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein","volume":"35","author":"Strong","year":"2007","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.ejmech.2021.113753_bib3","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00439-016-1683-5","article-title":"The Hn RNP family: insights into their role in health and disease","volume":"135","author":"Geuens","year":"2016","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ejmech.2021.113753_bib4","doi-asserted-by":"crossref","first-page":"10780","DOI":"10.1096\/fj.201900474R","article-title":"Isolation and characterization of soluble human full-length TDP-43 associated with neurodegeneration","volume":"33","author":"Vega","year":"2019","journal-title":"Faseb. J."},{"key":"10.1016\/j.ejmech.2021.113753_bib5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3389\/fnmol.2019.00301","article-title":"Structural insights into TDP-43 and effects of post-translational modifications","volume":"12","author":"Francois-Moutal","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ejmech.2021.113753_bib6","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1242\/jcs.038950","article-title":"Structural determinants of the cellular localization and shuttling of TDP-43","volume":"121","author":"Ayala","year":"2008","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.ejmech.2021.113753_bib7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40035-020-00219-w","article-title":"Maintaining the balance of TDP-43, mitochondria, and autophagy: a promising therapeutic strategy for neurodegenerative diseases","volume":"9","author":"Huang","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.ejmech.2021.113753_bib8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrn3121","article-title":"Gains or losses: molecular mechanisms of TDP-43-mediated neurodegeneration","volume":"13","author":"Lee","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejmech.2021.113753_bib9","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/nar\/gkp013","article-title":"Structural insights into TDP-43 in nucleic acid binding and domain interactions","volume":"37","author":"Kuo","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2021.113753_bib10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.tibs.2012.03.003","article-title":"TDP-43: gumming up neurons through protein-protein and protein-RNA interactions","volume":"37","author":"Buratti","year":"2012","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejmech.2021.113753_bib11","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/nsmb.2698","article-title":"Molecular basis of UG-rich RNA recognition by the human splicing factor TDP-43","volume":"20","author":"Lukavsky","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2021.113753_bib12","doi-asserted-by":"crossref","first-page":"20576","DOI":"10.1038\/srep20576","article-title":"A\u00a0molecular mechanism realizing sequence-specific recognition of nucleic acids by TDP-43","volume":"6","author":"Furukawa","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2021.113753_bib13","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1128\/jvi.69.6.3584-3596.1995","article-title":"Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs","volume":"69","author":"Ou","year":"1995","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2021.113753_bib14","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1128\/jvi.69.8.4906-4913.1995","article-title":"Human immunodeficiency virus type 1 TAR element revertant viruses define RNA structures required for efficient viral gene expression and replication","volume":"69","author":"Harrich","year":"1995","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2021.113753_bib15","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1093\/emboj\/20.7.1774","article-title":"Nuclear factor TDP-43 and SR proteins promote in\u00a0vitro and in\u00a0vivo CFTR exon 9 skipping","volume":"20","author":"Buratti","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2021.113753_bib16","doi-asserted-by":"crossref","first-page":"36337","DOI":"10.1074\/jbc.M104236200","article-title":"Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9","volume":"276","author":"Buratti","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113753_bib17","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1515\/hsz-2012-0115","article-title":"TDP-43 in central nervous system development and function: clues to TDP-43 associated neurodegeneration","volume":"393","author":"Sephton","year":"2012","journal-title":"Biol. Chem."},{"issue":"138","key":"10.1016\/j.ejmech.2021.113753_bib18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/jnc.13625","article-title":"J.\u00a0Physiological functions and pathobiology of TDP-43 and FUS\/TLS proteins","volume":"138","author":"Ratti","year":"2016","journal-title":"Neurochemistry"},{"key":"10.1016\/j.ejmech.2021.113753_bib19","doi-asserted-by":"crossref","first-page":"6826","DOI":"10.1074\/jbc.M109.061846","article-title":"TDP-43 is a developmentally regulated protein essential for early embryonic development","volume":"285","author":"Sephton","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113753_bib20","doi-asserted-by":"crossref","first-page":"16320","DOI":"10.1073\/pnas.1002176107","article-title":"Deletion of TDP-43 downregulates Tbc1d1, a gene linked to obesity, and alters body fat metabolism","volume":"107","author":"Chiang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2021.113753_bib21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41583-021-00431-1","article-title":"Triad of TDP-43 control in neurodegeneration: autoregulation, localization and aggregation","volume":"22","author":"Tziortzouda","year":"2021","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejmech.2021.113753_bib22","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotropic lateral sclerosis","volume":"134","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2021.113753_bib23","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","article-title":"TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"351","author":"Arai","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2021.113753_bib24","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1001\/archneur.64.10.1388","article-title":"TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis: protein misfolding diseases without amyloidosis","volume":"64","author":"Neumann","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ejmech.2021.113753_bib25","doi-asserted-by":"crossref","first-page":"18809","DOI":"10.1073\/pnas.0908767106","article-title":"TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration","volume":"106","author":"Wegorzewska","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2021.113753_bib26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnmol.2019.00025","article-title":"Molecular mechanisms of TDP-43 misfolding and pathology in amyotrophic lateral sclerosis","volume":"12","author":"Prasad","year":"2019","journal-title":"Front. Mol. Neurosci."},{"issue":"20","key":"10.1016\/j.ejmech.2021.113753_bib27","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.molmed.2013.11.003","article-title":"TDP-43 mediated neurodegeneration: towards a loss-of-function hypothesis?","volume":"20","author":"Broeck","year":"2014","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ejmech.2021.113753_bib28","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s13311-015-0338-x","article-title":"TDP-43 Proteinpathy and ALS: insights into disease mechanisms and therapeutic targets","volume":"12","author":"Scotter","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ejmech.2021.113753_bib29","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/brain\/awz078","article-title":"The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight?","volume":"142","author":"Hergesheimer","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.ejmech.2021.113753_bib30","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/ana.21154","article-title":"TDP-43 Immunoreactivity in hippocampal sclerosis and Alzheimer's disease","volume":"61","author":"Amador-Ortiz","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejmech.2021.113753_bib31","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/NEN.0b013e31817713b5","article-title":"Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies","volume":"67","author":"Uryu","year":"2008","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ejmech.2021.113753_bib32","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/NEN.0b013e31822c62cf","article-title":"Accumulation of transactive response DNA binding protein 43 in mild cognitive impairment and Alzheimer disease","volume":"70","author":"Tremblay","year":"2011","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ejmech.2021.113753_bib33","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00401-014-1269-z","article-title":"TDP-43 is a key player in the clinical features associated with Alzheimer's disease","volume":"127","author":"Josephs","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ejmech.2021.113753_bib34","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00401-017-1717-7","article-title":"Impact of multiple pathologies on the threshold for clinically overt dementia","volume":"134","author":"Kapasi","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ejmech.2021.113753_bib35","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/jnen\/nlw109","article-title":"Association of neuropathological markers in the parietal cortex with antemortem cognitive function in persons with mild cognitive impairment and Alzheimer's disease","volume":"76","author":"Tremblay","year":"2017","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ejmech.2021.113753_bib36","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awab099","article-title":"Comorbid neuropathological diagnoses in early versus late-onset Alzheimer's disease","author":"Spina","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.ejmech.2021.113753_bib37","doi-asserted-by":"crossref","first-page":"7607","DOI":"10.1073\/pnas.0900688106","article-title":"Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2021.113753_bib38","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fnins.2019.00335","article-title":"The pathobiology of TDP-43 C-terminal fragments in ALS and FTLD","volume":"13","author":"Berning","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejmech.2021.113753_bib39","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s12276-020-00513-7","article-title":"The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies","volume":"52","author":"Jo","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejmech.2021.113753_bib40","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/brain\/awz099","article-title":"Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report","volume":"142","author":"Nelson","year":"2019","journal-title":"Brain"},{"issue":"46","key":"10.1016\/j.ejmech.2021.113753_bib41","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/nan.12599","article-title":"Brain mural; cell loss in the parietal cortex in Alzheimer's disease correlates with cognitive decline and TDP-43 pathology","volume":"46","author":"Bourassa","year":"2020","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.ejmech.2021.113753_bib42","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41582-019-0207-z","article-title":"Piecing together a consensus on a TDP-43-related dementia syndrome","volume":"15","author":"Wood","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ejmech.2021.113753_bib43","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s12974-018-1350-y","article-title":"Age-related deregulation of TDP-43 after stroke enhances NF-\u03baB-mediated inflammation and neuronl damage","volume":"15","author":"Thammisetty","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejmech.2021.113753_bib44","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.celrep.2013.06.007","article-title":"Prion-like properties of pathological TDP-43 aggregates from diseased brains","volume":"4","author":"Nonaka","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2021.113753_bib45","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41593-018-0294-y","article-title":"TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates","volume":"22","author":"Laferriere","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejmech.2021.113753_bib46","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.conb.2019.11.018","article-title":"Prion-like properties of assembled TDP-43","volume":"61","author":"Nonaka","year":"2020","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.ejmech.2021.113753_bib47","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/15384047.2016.1250984","article-title":"Identification of TDP-43 as an oncogene in melanoma and its function during melanoma pathogenesis","volume":"18","author":"Zeng","year":"2017","journal-title":"Canc. Biol. Ther."},{"key":"10.1016\/j.ejmech.2021.113753_bib48","first-page":"E3426","article-title":"Loss of TDP-43 inhibits progression of triple-negative breast cancer in coordination with SRSF3","volume":"115","author":"Hao","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2021.113753_bib49","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/jnnp-2020-322983","article-title":"TDP-43 proteinopathies: a new wave of neurodegenerative diseases","volume":"92","author":"de Boer","year":"2021","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ejmech.2021.113753_bib50","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/ncomms1766","article-title":"The self-interaction of native TDP-43 terminus inhibits its degradation and contributes to early proteinopathies","volume":"3","author":"Wang","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2021.113753_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002338","article-title":"ALS-Causing mutations significantly perturb the self-assembly and interaction with nucleic acid of the intrinsically disordered prion-like domain of TDP-43","volume":"14","author":"Lim","year":"2016","journal-title":"PLoS Biol."},{"issue":"14","key":"10.1016\/j.ejmech.2021.113753_bib52","article-title":"Electrostatic repulsion governs TDP-43 C-terminal domain aggregation","volume":"14","author":"Mompean","year":"2016","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ejmech.2021.113753_bib53","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.bbapap.2017.10.001","article-title":"The physical forces mediating self-association and phase-separation in the C-terminal domain of TDP-43","volume":"1866","author":"Li","year":"2018","journal-title":"Biochim. Biophys. Acta Protein Proteonomics"},{"key":"10.1016\/j.ejmech.2021.113753_bib54","doi-asserted-by":"crossref","first-page":"6589","DOI":"10.1021\/cr400525m","article-title":"Classification of intrinsically disordered regions and proteins","volume":"114","author":"Lee","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2021.113753_bib55","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf4382","article-title":"Liquid phase separation in cell physiology and disease","volume":"357","author":"Shin","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2021.113753_bib56","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1146\/annurev-genet-112618-043527","article-title":"Liquid-liquid phase separation in disease","volume":"53","author":"Alberti","year":"2019","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.ejmech.2021.113753_bib57","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1021\/acs.biochem.6b01088","article-title":"Phase to phase with TDP-43","volume":"56","author":"Sun","year":"2017","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2021.113753_bib58","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1080\/15548627.2017.1384889","article-title":"The roles of intrinsic disorder-based liquid-liquid phase transitions in the \u201cDr. Jekyll-Mr. Hyde\u201d behavior of proteins involved in amyotrophic lateral sclerosis and frontotemporal lobar degeneration","volume":"13","author":"Uversky","year":"2017","journal-title":"Autophagy"},{"key":"10.1016\/j.ejmech.2021.113753_bib59","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/jmcb\/mjaa049","article-title":"Role and the therapeutic potential of liquid-liquid phase separation in amyotrophic lateral sclerosis","volume":"13","author":"Pakravan","year":"2021","journal-title":"J.\u00a0Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2021.113753_bib60","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1021\/acschembio.0c00494","article-title":"An allosteric modulator of RNA binding targeting the N-terminal domain of TDP-43 yields neuroprotective properties","volume":"15","author":"Mollasalehi","year":"2020","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2021.113753_bib61","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/bph.15148","article-title":"Targeting TDP-43 proteinopathy with drugs and drug-like small molecules","volume":"178","author":"Buratti","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113753_bib62","doi-asserted-by":"crossref","first-page":"18619","DOI":"10.1073\/pnas.1413994112","article-title":"TDP-43 N terminus encodes a novel ubiquitin-like fold and its unfolded form in equilibrium that can be shifted by binding to ssDNA","volume":"111","author":"Qin","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2021.113753_bib63","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41467-017-00062-0","article-title":"Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation","volume":"8","author":"Afroz","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2021.113753_bib64","doi-asserted-by":"crossref","first-page":"101159","DOI":"10.1016\/j.isci.2020.101159","article-title":"Purification and structural characterization of aggregation-prone human TDP-43 involved in neurodegenerative diseases","volume":"23","author":"Wright","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.ejmech.2021.113753_bib65","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/febs.13651","article-title":"The TDP-43 N-terminal domain structure at high resolution","volume":"283","author":"Mompean","year":"2016","journal-title":"FEBS J."},{"key":"10.1016\/j.ejmech.2021.113753_bib66","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s10571-009-9489-9","article-title":"TDP-43 dimerizes in human cells in cultures, Cell","volume":"30","author":"Shiina","year":"2010","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejmech.2021.113753_bib67","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201797452","article-title":"A\u00a0single N-terminal phosphomimic disrupts polymerization, phase separation, and RNA splicing","volume":"37","author":"Wang","year":"2018","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2021.113753_bib68","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bbrc.2012.07.071","article-title":"The N-terminus of TDP-43 promotes its oligomerization and enhances DNA binding affinity","volume":"425","author":"Chang","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2021.113753_bib69","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.molcel.2018.07.002","article-title":"Poly(ADP-ribose) prevents pathological phase separation of TDP-43 by promoting liquid demixing and stress granule localization","volume":"71","author":"McGurk","year":"2018","journal-title":"Mol. Cell."},{"key":"10.1016\/j.ejmech.2021.113753_bib70","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.3390\/cancers12082121","article-title":"Histone demethylase KDM5B as a therapeutic target for cancer therapy","volume":"12","author":"Jose","year":"2020","journal-title":"Cancers"},{"issue":"57","key":"10.1016\/j.ejmech.2021.113753_bib71","doi-asserted-by":"crossref","first-page":"6923","DOI":"10.1021\/acs.biochem.8b00910","article-title":"Poly(ADP-ribose) engages the TDP-43 nuclear localization sequence to regulate granulo-filamentous aggregation","volume":"57","author":"McGurk","year":"2018","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2021.113753_bib72","doi-asserted-by":"crossref","first-page":"11992","DOI":"10.1074\/jbc.M117.775965","article-title":"Point mutations in the N-terminal domain of transactive response DNA-binding protein 43 kDa (TDP-43) compromise its stability, dimerization, and functions","volume":"292","author":"Mompean","year":"2017","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113753_bib73","doi-asserted-by":"crossref","first-page":"13975","DOI":"10.1021\/jp4065467","article-title":"Poly(4-styrenesulfonate) as an inhibitor of A\u03b240 amyloid fibril formation","volume":"45","author":"Ojha","year":"2013","journal-title":"J.\u00a0Phys. Chem. B"},{"key":"10.1016\/j.ejmech.2021.113753_bib74","doi-asserted-by":"crossref","first-page":"P1188","DOI":"10.1016\/j.cell.2012.02.022","article-title":"The amyloid state of proteins in human diseases","volume":"148","author":"Eisenberg","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2021.113753_bib75","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1093\/nar\/gkt1407","article-title":"The crystal structure of TDP-43 RRM1-DNA complex reveals the specific recognition for UG- and TG-rich nucleic acids","volume":"42","author":"Kuo","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2021.113753_bib76","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nrn3032","article-title":"Neurodegenerative disease: a target map for TDP43","volume":"12","author":"Whalley","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejmech.2021.113753_bib77","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.celrep.2019.03.093","article-title":"An intramolecular salt bridge linking TDP-43 RNA binding, protein stability, and TDP-43-dependent neurodegeneration","volume":"27","author":"Flores","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2021.113753_bib78","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nchembio.1563","article-title":"Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models","volume":"10","author":"Barmada","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2021.113753_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012247","article-title":"TDP-43 mediated neuron loss in\u00a0vivo requires RNA-binding activity","volume":"5","author":"Voigt","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2021.113753_bib80","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1093\/hmg\/ddt296","article-title":"RNA binding mediates neurotoxicity in the transgenic drosophila model of TDP-43 proteinopathy","volume":"22","author":"Ihara","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejmech.2021.113753_bib81","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fmolb.2019.00154","article-title":"To be or not to be..toxic \u2013is RNA association with TDP-43 complexes deleterious or protective in neurodegeneration?","volume":"6","author":"Loganathan","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ejmech.2021.113753_bib82","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1073\/pnas.1317317111","article-title":"Disease causing mutants of TDP-43 nucleic acid binding domains are resistant to aggregation and have increased stability and half-life","volume":"111","author":"Austin","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2021.113753_bib83","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3389\/fnmol.2018.00372","article-title":"The RNA-recognition motifs of TAR DNA-binding protein 43 may play a role in the aberrant self-assembly of the protein","volume":"11","author":"Zacco","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ejmech.2021.113753_bib84","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.bpj.2018.09.011","article-title":"Characterization of TDP-43 RRM2 partially folded states and their significance to ALS pathogenesis","volume":"115","author":"Tavella","year":"2018","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejmech.2021.113753_bib85","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1093\/brain\/awz313","article-title":"RRM adjacent TARDBP mutations disrupt RNA binding and enhance TDP-43 proteinopathy","volume":"142","author":"Chen","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.ejmech.2021.113753_bib86","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.neuron.2019.05.048","article-title":"Small-molecule modulation of TDP-43 recruitment to stress granules prevents persistent TDP-43 accumulation in ALS\/FTD","volume":"103","author":"Fang","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2021.113753_bib87","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bbrc.2019.11.088","article-title":"ATP is a cryptic binder of TDP-43 RRM domains to enhance stability and inhibits ALS\/AD-associated fibrillation","volume":"522","author":"Dang","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2021.113753_bib88","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.bbrc.2020.01.122","article-title":"ALS-causing D169G mutation disrupts the ATP-binding capacity of TDP-43 RRM1 domain","volume":"524","author":"Dang","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2021.113753_bib89","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/s41598-020-80524-6","article-title":"Tethering-induced destabilization and ATP-bidning for tandem RRM domains of ALS-causing TDP-43 and hnRNPA1","volume":"11","author":"Dang","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2021.113753_bib90","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1172\/JCI123931","article-title":"Virus-mediated delivery of antibody targeting TAR DNA-binding protein-43 mitigates associated neuropathology","volume":"129","author":"Pozzi","year":"2019","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ejmech.2021.113753_bib91","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1021\/acschembio.9b00481","article-title":"Small molecule targeting TDP-43's RNA recognition motifs reduces locomotor defects in a Drosophila model of amyotrophic lateral sclerosis (ALS)","volume":"14","author":"Francois-Moutal","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2021.113753_bib92","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.3390\/ijms20133230","article-title":"NMR fragment-based screening against tandem RNA recognition motifs of TDP-43","volume":"20","author":"Nshogoza","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2021.113753_bib93","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1177\/1087057110382778","article-title":"Development of a novel nonradiometric assay for nucleic acid binding to TDP-43 suitable for high-throughput screening using alphascreen technology","volume":"15","author":"Cassel","year":"2010","journal-title":"J.\u00a0Biomol. Screen"},{"key":"10.1016\/j.ejmech.2021.113753_bib94","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/j.febslet.2009.06.042","article-title":"Methylene blue and dimebon inhibit aggregation of TDP-43 in cellular models","volume":"21","author":"Yamashita","year":"2009","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejmech.2021.113753_bib95","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.neuron.2019.01.048","article-title":"RNA binding antagonizes neurotoxic phase transitions of TDP-43, RNA binding antagonizes neurotoxic phase transitions of TDP-43","volume":"102","author":"Mann","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2021.113753_bib96","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb3774","article-title":"C9orf72 poly(GR) aggregation induces TDP-43 proteinopathy","volume":"12","author":"Cook","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmech.2021.113753_bib97","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1093\/hmg\/ddp275","article-title":"Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43","volume":"18","author":"Nonaka","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejmech.2021.113753_bib98","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41594-018-0064-2","article-title":"Atomic structures of TDP-43 LCD segments and insights into reversible or pathogenic aggregation","volume":"25","author":"Guenther","year":"2018","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2021.113753_bib99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4161\/pri.5.1.14265","article-title":"Implications of the prion-related Q\/N domains in TDP-43 and FUS","volume":"5","author":"Udan","year":"2011","journal-title":"Prion"},{"key":"10.1016\/j.ejmech.2021.113753_bib100","doi-asserted-by":"crossref","first-page":"19614","DOI":"10.1074\/jbc.M113.463828","article-title":"Structural transformation of the amyloidogenic core region of TDP-43 protein initiates its aggregation and cytoplasmic inclusion","volume":"288","author":"Jiang","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113753_bib101","doi-asserted-by":"crossref","first-page":"13302","DOI":"10.1074\/jbc.M800342200","article-title":"Disturbance of nuclear and cytoplasmic TAR DNA binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation","volume":"283","author":"Winton","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113753_bib102","doi-asserted-by":"crossref","first-page":"6439","DOI":"10.1073\/pnas.0802082105","article-title":"A\u00a0yeast TDP-43 proteinopathy model: exploring the molecular determinants of TDP-43 aggregation and cellular toxicity","volume":"105","author":"Johnson","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2021.113753_bib103","doi-asserted-by":"crossref","first-page":"10530","DOI":"10.1523\/JNEUROSCI.3421-07.2007","article-title":"Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43","volume":"27","author":"Zhang","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ejmech.2021.113753_bib104","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/WCO.0b013e3283168d1d","article-title":"The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia","volume":"21","author":"Mackenzie","year":"2008","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.ejmech.2021.113753_bib105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.adgen.2015.07.001","article-title":"Functional significance of TDP-43 mutations in disease","volume":"91","author":"Buratti","year":"2015","journal-title":"Adv. Genet."},{"key":"10.1016\/j.ejmech.2021.113753_bib106","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1038\/s41467-019-12740-2","article-title":"Phase separation-deficient TDP43 remains functional in splicing","volume":"10","author":"Schmidt","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2021.113753_bib107","doi-asserted-by":"crossref","first-page":"23928","DOI":"10.1038\/srep23928","article-title":"Two mutations G335D and Q343R within the amyloidogenic core region of TDP-43 influence its aggregation and inclusion formation","volume":"6","author":"Jiang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2021.113753_bib108","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s41594-019-0248-4","article-title":"Cryo-EM structures of four polymorphic TDP-43 amyloid cores","volume":"26","author":"Cao","year":"2019","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2021.113753_bib109","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s41467-021-21912-y","article-title":"Cryo-EM structure of amyloid fibrils formed by the entire low complexity domain of TDP-43","volume":"12","author":"Li","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2021.113753_bib110","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12104-020-10002-7","article-title":"NMR assignments for the C-terminal domain of human TDP-43, Biomol","volume":"15","author":"Uceda","year":"2021","journal-title":"NMR Assign"},{"key":"10.1016\/j.ejmech.2021.113753_bib111","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cell.2015.09.015","article-title":"Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization","volume":"163","author":"Molliex","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2021.113753_bib112","doi-asserted-by":"crossref","first-page":"6090","DOI":"10.1074\/jbc.AC117.001037","article-title":"TAR DNA-binding protein 43 (TDP-43) liquid-liquid phase separation is mediated by just few aromatic residues","volume":"293","author":"Li","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113753_bib113","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.1073\/pnas.1912055117","article-title":"TDP-43 helical structure tunes liquid-liquid phase separation and function","volume":"117","author":"Conicella","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2021.113753_bib114","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1021\/la404710w","article-title":"Self-assembling properties of peptides derived from TDP-43 C-terminal fragment","volume":"30","author":"Saini","year":"2014","journal-title":"Langmuir"},{"key":"10.1016\/j.ejmech.2021.113753_bib115","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nsmb.2053","article-title":"An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity","volume":"18","author":"Guo","year":"2011","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.ejmech.2021.113753_bib116","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.abb.2014.01.007","article-title":"Structural characterization of the minimal segment of TDP-43 competent for aggregation","volume":"545","author":"Mompean","year":"2014","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejmech.2021.113753_bib117","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev-biochem-061516-045104","article-title":"Structural studies of amyloid proteins at the molecular level","volume":"86","author":"Eisenberg","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejmech.2021.113753_bib118","article-title":"Structure-based discovery of fiber-binding compounds that reduce the cytotoxicity of amyloid beta","volume":"2","author":"Jiang","year":"2013","journal-title":"eLife"},{"key":"10.1016\/j.ejmech.2021.113753_bib119","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nchem.2889","article-title":"Structure-based inhibitors of tau aggregation","volume":"10","author":"Seidler","year":"2018","journal-title":"Nat. Chem."},{"key":"10.1016\/j.ejmech.2021.113753_bib120","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1021\/cn400151a","article-title":"Tau-derived-hexapeptide 306VQIVYK311 aggregation inhibitors: nitrocatechol moiety as a pharmacophore in drug design","volume":"4","author":"Mohamed","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2021.113753_bib121","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1038\/s41467-020-19211-z","article-title":"Small molecules as potent biphasic modulators of protein liquid-liquid separation","volume":"11","author":"Babinchak","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2021.113753_bib122","doi-asserted-by":"crossref","first-page":"P4107","DOI":"10.1074\/jbc.M111.308668","article-title":"Different 8-hydroxyquinolines protect models of TDP-43 protein, \u03b1-synuclein, and polyglutamine proteotoxicity through distinct mechanisms","volume":"287","author":"Tardiff","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113753_bib123","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042277","article-title":"Inhibition of TDP-43 accumulation by bis(thiosemicarbazonato)-copper complexes","volume":"7","author":"Parker","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2021.113753_bib124","doi-asserted-by":"crossref","first-page":"39490","DOI":"10.1038\/srep39490","article-title":"An acridine derivative, [4,5-bis{N-carboxy methylimidazolium)methyl}acridine dibromide, shows anti-TDP-43 aggregation effect in ALS disease models","volume":"6","author":"Prasad","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2021.113753_bib125","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijbiomac.2020.01.032","article-title":"Computational insights into mechanism of AIM4-mediated inhibition of aggregation of TDP-43 protein implicated in ALS and evidence for in\u00a0vitro inhibition of liquid-liquid phase separation (LLPS) of TDP-432C-A315T by AIM4","volume":"147","author":"Girdhar","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejmech.2021.113753_bib126","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001080","article-title":"Towards a pharmacophore for amyloid","volume":"9","author":"Landau","year":"2011","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ejmech.2021.113753_bib127","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/cbdd.12552","article-title":"Curcumin binding to beta amyloid: a computational study","volume":"86","author":"Rao","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2021.113753_bib128","doi-asserted-by":"crossref","first-page":"5956","DOI":"10.1002\/anie.201008276","article-title":"The amyloid-Congo red interface at atomic resolution","volume":"50","author":"Schutz","year":"2011","journal-title":"Angew. Chem., Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2021.113753_bib129","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1021\/acs.biochem.9b00905","article-title":"Modulating ALS-related amyloidogenic TDP-43307-319 oligomeric aggregates with computationally derived therapeutic molecules","volume":"59","author":"Laos","year":"2020","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2021.113753_bib130","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3762\/bjoc.9.82","article-title":"Recent progress in the discovery of small molecules for the treatment of amyotrophic lateral sclerosis (ALS)","volume":"9","author":"Limpert","year":"2013","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.ejmech.2021.113753_bib131","first-page":"713","article-title":"Prevention of transthyretin amyloid disease by changing protein misfolding energetics","volume":"299","author":"Hammarstrom","year":"2003","journal-title":"J.\u00a0W. Kelly, Science"},{"key":"10.1016\/j.ejmech.2021.113753_bib132","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2021.113753_bib133","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/14728222.2018.1439923","article-title":"TDP-43 post-translational modifications in health and disease","volume":"22","author":"Buratti","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ejmech.2021.113753_bib134","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41582-020-0330-x","article-title":"Development of disease-modifying drugs for frontotemporal dementia spectrum disorders","volume":"16","author":"Panza","year":"2020","journal-title":"Nat. Rev. Neurol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421006024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421006024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:29:26Z","timestamp":1759328966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421006024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":134,"alternative-id":["S0223523421006024"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113753","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strategies in the design and development of (TAR) DNA-binding protein 43 (TDP-43) binding ligands","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113753","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2021 Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113753"}}